Alia Therapeutics S.R.L. is a targeted Gene Editing founded in 2018 by Antonio Casini, Anna Cereseto and Gianluca Petris.
Targeted Gene Editing
Alia Therapeutics, is an Italian CRISPR company, developing therapeutic approaches to treat incurable genetic diseases. Alia’s CRISPR-based genome editing tools allow specificity in modifying the genome, coupled with safe and efficient delivery into target cells.